Icon ICLR
NASDAQ ICLR
$168.97 +4.63 (+2.82%)
At close: Oct 14, 2026 · 4:00 PM EDT

Icon (ICLR) EBITDA Margin (2009 - 2026)

Updated

Icon's EBITDA Margin came in at 11.15% for the quarter ended Jun 30, 2026, down 5.04 percentage points from 16.19% a year earlier and down 1.90 percentage points from the prior quarter.

Analysis

Icon (ICLR) EBITDA Margin (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Icon reported EBITDA Margin of 11.26%, down 6.11 percentage points year-over-year; for the year ended Dec 31, 2025, it was 16.34%, down 3.48 percentage points from the prior year.

  • EBITDA Margin carries a five-year change of -0.04 percentage points (years ended Dec 2020 to Dec 2025).
  • Going back by year, EBITDA Margin was 19.81% in the year ended Dec 31, 2024 (+1.10 pp), 18.71% in the year ended Dec 31, 2023 (+0.85 pp), 17.86% in the year ended Dec 31, 2022 (+4.97 pp) and 12.89% in the year ended Dec 31, 2021 (-3.49 pp).
  • The five-year range for quarterly EBITDA Margin is 7.96% (the quarter ended Sep 30, 2021) to 20.98% (the quarter ended Mar 31, 2024).
  • Year-over-year, EBITDA Margin has declined for eight consecutive quarters, with an average year-over-year change of -4.28 percentage points over the last eight quarters.
  • The fastest year-over-year change in EBITDA Margin over five years came in the quarter ended Sep 30, 2022 (a gain of 12.11 percentage points), and the weakest in the quarter ended Sep 30, 2021 (a drop of 10.58 percentage points).
  • Business Quant data shows ICLR's EBITDA Margin at 13.06% (quarter ended Mar 31, 2026), 11.71% (quarter ended Dec 31, 2025) and 9.13% (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Iqvia Holdings 43.58 Bn 35.28 Bn 1.44 Bn 18.41%
2 Medpace Holdings 17.39 Bn 15.45 Bn 201.64 Mn 21.71%
3 Charles River Laboratories International 14.59 Bn 13.78 Bn 363.37 Mn 18.64%
4 Icon 13.27 Bn 10.38 Bn 479.29 Mn 11.15%
5 Fortrea Holdings 2.03 Bn 1.41 Bn 139.20 Mn 5.07%
6 Ginkgo Bioworks Holdings 716.57 Mn -45.52 Mn 18.44 Mn -229.38%
7 Evotec SE 506.10 Mn -1.10 Bn - -
8 Champions Oncology 66.85 Mn 41.93 Mn 7.70 Mn -0.62%
9 MindWalk Holdings 63.92 Mn 27.58 Mn 1.61 Mn -152.92%
10 Natural Alternatives International 6.75 Mn -21.33 Mn 1.73 Mn -34.75%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.15%
Mar 31, 2026 13.06%
Dec 31, 2025 0.91%
Sep 30, 2025 9.13%
Jun 30, 2025 16.19%
Mar 31, 2025 16.10%
Dec 31, 2024 16.92%
Sep 30, 2024 18.72%
Jun 30, 2024 18.69%
Mar 31, 2024 20.98%
Dec 31, 2023 18.38%
Sep 30, 2023 20.19%
Jun 30, 2023 17.72%
Mar 31, 2023 18.52%
Dec 31, 2022 17.83%
Sep 30, 2022 20.08%
Jun 30, 2022 16.81%
Mar 31, 2022 16.70%
Dec 31, 2021 15.52%
Sep 30, 2021 7.96%
API Access

Icon EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ICLR&period=max&api_key=YOUR_API_KEY